Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Waters Corporation WAT

Healthcare  —  Diagnostics & Research
433.54 3.24 0.75% as of 25 Sep
Market cap
$42.3B
P/E
108×
S&P 500 Member Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Waters Corporation (WAT) Business Profile

Updated before January 2025

Company Overview

Waters Corporation (WAT) is a leading global provider of analytical instruments, software, and services for the life sciences, materials science, and food industries. Founded in 1958 by James L. Waters, the company is headquartered in Milford, Massachusetts, USA. Over the decades, Waters Corporation has established itself as a pioneer in liquid chromatography, mass spectrometry, and thermal analysis technologies. The company operates in over 35 countries and employs approximately 7,800 people worldwide.

The leadership team at Waters Corporation is committed to driving innovation and operational excellence. Udit Batra, who became the President and Chief Executive Officer in September 2020, brings extensive experience in the life sciences and analytical instruments industries. Under his leadership, the company has focused on enhancing customer-centric solutions and expanding its global footprint.

Core Business Segments

Waters Corporation operates through three primary business segments, offering a diverse range of products and services:

1. Liquid Chromatography (LC)

Waters is a global leader in liquid chromatography systems, which are widely used in pharmaceutical, environmental, and food safety applications. Key products include:

  • ACQUITY UPLC Systems: Ultra-performance liquid chromatography systems designed for high-resolution and high-speed separations.
  • Alliance HPLC Systems: High-performance liquid chromatography systems for routine analysis.
  • Columns and Consumables: A wide range of chromatography columns and sample preparation products.

2. Mass Spectrometry (MS)

Waters offers advanced mass spectrometry systems that enable precise molecular analysis. These systems are used in drug discovery, clinical diagnostics, and environmental testing. Key products include:

  • Xevo Mass Spectrometers: High-sensitivity instruments for qualitative and quantitative analysis.
  • SYNAPT G2-Si: A high-resolution mass spectrometer for structural elucidation and biomolecular analysis.
  • MassLynx Software: Data acquisition and analysis software for mass spectrometry workflows.

3. Thermal Analysis and Informatics

Waters provides thermal analysis instruments and informatics solutions to support research and quality control processes. Key offerings include:

  • TA Instruments: Thermal analysis systems for materials characterization.
  • Empower Chromatography Software: A comprehensive data management platform for chromatography and mass spectrometry.
  • NuGenesis Lab Management System: A scientific data management system for laboratory workflows.

Business Model

Waters Corporation operates a hybrid business model that integrates products, services, and software solutions to deliver comprehensive analytical workflows. The company generates revenue through:

  • Product Sales: A significant portion of revenue comes from the sale of analytical instruments, consumables, and software.
  • Service Contracts: Waters offers maintenance, repair, and training services to ensure optimal instrument performance.
  • Recurring Revenue Streams: Consumables, software licenses, and service agreements provide a stable and predictable revenue base.

Waters’ business model emphasizes customer retention through high-quality products and exceptional service. The company invests heavily in research and development (R&D) to maintain its technological leadership and address emerging market needs.

Strategic Direction

Waters Corporation is focused on driving growth through innovation, sustainability, and market expansion. Key strategic initiatives include:

  • Innovation in Life Sciences: Developing next-generation analytical instruments and software to support drug discovery, personalized medicine, and clinical diagnostics.
  • Sustainability Goals: Reducing the environmental impact of its operations and products. Waters has committed to achieving carbon neutrality by 2040.
  • Geographic Expansion: Strengthening its presence in high-growth markets such as Asia-Pacific and Latin America.
  • Digital Transformation: Leveraging data analytics and cloud-based solutions to enhance laboratory efficiency and decision-making.

Competitive Landscape

Waters Corporation operates in a highly competitive market, facing competition from both large multinational corporations and specialized niche players. Key competitors include:

  • Agilent Technologies: A major player in chromatography and mass spectrometry.
  • Thermo Fisher Scientific: Offers a broad portfolio of analytical instruments and laboratory solutions.
  • Shimadzu Corporation: Known for its innovative chromatography and spectrometry systems.
  • PerkinElmer: Focuses on life sciences and environmental testing solutions.
  • Bruker Corporation: Specializes in mass spectrometry and molecular analysis.

Waters differentiates itself through its focus on high-performance systems, customer-centric solutions, and a strong commitment to R&D.

Risk Factors

Waters Corporation faces several risks that could impact its business operations and financial performance:

  • Market Dependence: A significant portion of revenue comes from the pharmaceutical and life sciences sectors, making the company vulnerable to industry-specific downturns.
  • Supply Chain Disruptions: Dependence on global supply chains exposes Waters to risks related to material shortages, transportation delays, and geopolitical tensions.
  • Regulatory Challenges: Compliance with stringent regulations in the pharmaceutical and food industries can increase operational complexity and costs.
  • Technological Obsolescence: Rapid advancements in analytical technologies require continuous innovation to stay competitive.

Recent Developments

Waters Corporation has made significant strides in innovation and corporate strategy in recent years:

  • New Product Launches: The company introduced the ACQUITY PREMIER System, designed to improve analytical performance and reduce sample variability.
  • Acquisitions: Waters acquired Wyatt Technology, a leader in light scattering and molecular characterization, to expand its biopharmaceutical analysis capabilities.
  • Sustainability Initiatives: Waters has implemented energy-efficient manufacturing processes and launched eco-friendly product packaging.
  • Global Developments: The COVID-19 pandemic accelerated demand for analytical instruments in vaccine development and quality control.

Investment Considerations

Strengths:

  • Strong market position in liquid chromatography and mass spectrometry.
  • Diversified revenue streams from products, services, and software.
  • Robust R&D capabilities and a history of innovation.
  • Growing demand for analytical instruments in life sciences and food safety.

Risks:

  • Dependence on a few key markets and industries.
  • Exposure to supply chain disruptions and geopolitical risks.
  • High competition from established players and new entrants.

Investors should weigh these factors when considering Waters Corporation as a potential investment.

Conclusion

Waters Corporation is a global leader in analytical instruments and software, with a strong focus on innovation and customer-centric solutions. The company is well-positioned to capitalize on growth opportunities in life sciences, food safety, and environmental testing. While it faces challenges such as market dependence and supply chain risks, Waters’ commitment to sustainability and digital transformation provides a solid foundation for future growth. With its strong market position and strategic initiatives, Waters Corporation is poised to maintain its leadership in the analytical instruments industry.